-
Founded in:
1989-07-07 -
Country:
China -
Address:
Shantou Free Trade Zone A08-1 plot -
Tax NO.:
9144050061752711XR -
Registered Funds:
44.7 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dequalinium chloride |
This product is a cationic surfactant with a broad-spectrum antibacterial effect and is effective against common pathogenic bacteria and fungal infections in the oral cavity and throat.
More
This product is a cationic surfactant with a broad-spectrum antibacterial effect and is effective against common pathogenic bacteria and fungal infections in the oral cavity and throat. |
522-51-0 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin Acetate |
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome.
More
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome. |
55881-07-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin Acetate |
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome.
More
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome. |
55881-07-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin Acetate |
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome.
More
This product is a macrolide antibiotic. It has antibacterial effects on Staphylococcus, Streptococcus (excluding faecal Streptococcus), Peptostreptococcus, Bacteroides (excluding Bacteroides fragilis) and Haemophilus influenzae, and has an inhibitory effect on the growth of Mycoplasma pneumoniae. Some erythromycin-resistant Staphylococcus aureus are also sensitive to it. Its mechanism of action is to inhibit bacterial protein synthesis by binding to the 70S subunit of the bacterial ribosome. |
55881-07-7 | 2 |